Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders

The above mentioned conference was organized in order to examine the current most innovative and important approaches to new drug development, whilst providing updates on the most recent approaches to the treatment of the major mental illnesses and some aspects of substance abuse. Study of the biological factors underlying mental illness continues to be a source of strategies for new drug development as does new information from molecular biology about receptor subtypes. Computer modelling can now provide invaluable assistance in quickly suggesting the structure of compounds with the desired specificity and potency. New antipsychotic drugs for the treatment of schizophrenia are constantly being developed, along with compounds which are antipsychotic and which do not produce extrapyramidal symptoms. This volume is a clear presentation of how the conference approached and discussed these latest advances and developments. It should serve as a catalyst for yet additional new approaches to drug discovery, development and treatment for mental disorders.
 
The above mentioned conference was organized in order to examine the current most innovative and important approaches to new drug development, whilst providing updates on the most recent approaches to the treatment of the major mental illnesses and some aspects of substance abuse. Study of the biological factors underlying mental illness continues to be a source of strategies for new drug development as does new information from molecular biology about receptor subtypes. Computer modelling can now provide invaluable assistance in quickly suggesting the structure of compounds with the desired specificity and potency. New antipsychotic drugs for the treatment of schizophrenia are constantly being developed, along with compounds which are antipsychotic and which do not produce extrapyramidal symptoms. This volume is a clear presentation of how the conference approached and discussed these latest advances and developments. It should serve as a catalyst for yet additional new approaches to drug discovery, development and treatment for mental disorders.